# Next Generation Sequencing Versus Traditional Cultures for Clinically Infected Penile Implants: Impact of Culture Identification on Outcomes

> **NCT05287438** · NA · UNKNOWN · sponsor: **MicroGenDX** · enrollment: 40 (estimated)

## Conditions studied

- Penile Implantation
- Infections

## Interventions

- **DIAGNOSTIC_TEST:** Next-Generation DNA Sequencing
- **DIAGNOSTIC_TEST:** Standard Culture

## Key facts

- **NCT ID:** NCT05287438
- **Lead sponsor:** MicroGenDX
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-10-27
- **Primary completion:** 2023-10-31
- **Final completion:** 2024-10-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2022-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05287438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05287438, "Next Generation Sequencing Versus Traditional Cultures for Clinically Infected Penile Implants: Impact of Culture Identification on Outcomes". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT05287438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*